title: Eradication of Mycoplasma contaminations from cell cultures.
abstract: Mycoplasma contaminations have a multitude of effects on cultured cell lines that may influence the results of experiments or pollute bioactive substances isolated from the eukaryotic cells. The elimination of mycoplasma contaminations from cell cultures with antibiotics has been proven to be a practical alternative to discarding and re-establishing important or irreplaceable cell lines. Different fluoroquinolones, tetracyclins, pleuromutilins, and macrolides shown to have strong anti-mycoplasma properties are employed for the decontamination. These antibiotics are applied as single treatments, as combination treatment of two antibiotics in parallel or successively, or in combination with a surface-active peptide to enhance the action of the antibiotic. The protocols in this unit allow eradication of mycoplasmas, prevention of the development of resistant mycoplasma strains, and potential cure of heavily contaminated and damaged cells. Consistent and permanent alterations to eukaryotic cells attributable to the treatment have not been demonstrated.
authors.affiliation: Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.
authors.forename: Cord C
authors.initials: CC
authors.lastname: Uphoff
authors.affiliation: Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.
authors.forename: Hans G
authors.initials: HG
authors.lastname: Drexler
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D018929:Cell Culture Techniques / Q000379:methods*; D006801:Humans; D009174:Mycoplasma; D009175:Mycoplasma Infections / Q000517:prevention & control*
chemical_list: D000900:Anti-Bacterial Agents
keywords: antibiotic treatment; contamination; elimination; mycoplasma
references.citation: Armstrong, S.E. , Mariano, J.A. , and Lundin, D.J. 2010. The scope of mycoplasma contamination within the biopharmaceutical industry. Biologicals 38:211-213.
references.citation: Drexler, H.G. and Uphoff, C.C. 2002. Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention. Cytotechnology 39:75-90.
references.citation: Nir-Paz, R. , Prévost, M.-C. , Nicolas, P. , Blanchard, A. , and Wróblewski, H. 2002. Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures. Antimicrob. Agents Chemother. 46:1218-1225.
references.citation: Rottem, S. and Barile, M.F. 1993. Beware of mycoplasmas. Tibtech 11:143-151.
references.citation: Schmidt, J. and Erfle, V. 1984. Elimination of mycoplasma from cell cultures and establishment of mycoplasma-free cell lines. Exp. Cell Res. 152:565-570.
references.citation: Uphoff, C.C. and Drexler, H.G. 2001. Prevention of mycoplasma contamination in leukemia-lymphoma cell lines. Human Cell 14:244-247.
references.citation: Uphoff, C.C. and Drexler, H.G. 2002. Comparative antibiotic eradication of mycoplasma infections from continuous cell lines. In Vitro Cell. Dev. Biol. Anim. 38:86-89.
references.citation: Uphoff, C.C. and Drexler, H.G. 2010. Contamination of cell cultures, mycoplasma. In The Encyclopedia of Industrial Biotechnology ( M. Flickinger , ed.) pp. 3611-3630. John Wiley & Sons, Hoboken, New Jersey.
references.citation: Uphoff, C.C. , Denkmann, S.A. , and Drexler H.G. 2012. Treatment of mycoplasma contamination in cell cultures with Plasmocin. J. Biomed. Biotechnol. 2012:267678.
references.citation: Yavlovich, A. and Rottem, S. 2007. Binding of host extracellular matrix proteins to Mycoplasma fermentans and its effect on adherence to, and invasion of HeLa cells. FEMS Microbiol. Lett. 266:156-162.